Structure Therapeutics
stock3 TerminalDu willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnen
Structure Therapeutics Kurse
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit |
|---|---|---|---|---|---|
| Nasdaq | |||||
| Nasdaq Basic | |||||
| Cboe BZX |
Wertentwicklung (Nasdaq)
-7,98 %
Intraday
-11,91 %
1 Woche
-23,62 %
1 Monat
-26,15 %
Seit Jahresbeginn
-41,41 %
1 Jahr
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)26,61-66,38
- Jahrestief / Hoch ($)29,48-62,74
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Beschreibung
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
